Predictors of Influenza PCR Positivity in Acute Exacerbations of Chronic Obstructive Pulmonary Disease

References

• Kim V, Aaron SD. What is a COPD exacerbation? Current definitions, pitfalls, challenges and opportunities for improvement. Eur Respir J. 2018;52(5):1801261. doi:10.1183/13993003.01261-2018
   PubMed Web of Science ®Google Scholar
• MacIntyre N, Huang YC. Acute exacerbations and respiratory failure in chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2008;5(4):530–535. doi:10.1513/pats.200707-088ET
   PubMedGoogle Scholar
• Varkey JB, Varkey B. Viral infections in patients with chronic obstructive pulmonary disease. Curr Opin Pulm Med. 2008;14(2):89–94. doi:10.1097/MCP.0b013e3282f4a99f
   PubMed Web of Science ®Google Scholar
• Mohan A, Chandra S, Agarwal D, et al. Prevalence of viral infection detected by PCR and RT-PCR in patients with acute exacerbation of COPD: a systematic review. Respirology. 2010;15(3):536–542. doi:10.1111/j.1440-1843.2010.01722.x
   PubMed Web of Science ®Google Scholar
• Mallia P, Johnston SL. Influenza infection and COPD. Int J Chron Obstruct Pulmon Dis. 2007;2(1):55–64. doi:10.2147/copd.2007.2.1.55
   PubMedGoogle Scholar
• Seemungal T, Harper-Owen R, Bhowmik A, et al. Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001;164(9):1618–1623. doi:10.1164/ajrccm.164.9.2105011
   PubMed Web of Science ®Google Scholar
• Mallia P, Footitt J, Sotero R, et al. Rhinovirus infection induces degradation of antimicrobial peptides and secondary bacterial infection in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012;186(11):1117–1124. doi:10.1164/rccm.201205-0806OC
   PubMed Web of Science ®Google Scholar
• Kaiser L, Wat C, Mills T, Mahoney P, Ward P, Hayden F. Impact of oseltamivir treatment on influenza-related lower respiratory tract complications and hospitalizations. Arch Intern Med. 2003;163(14):1667–1672. doi:10.1001/archinte.163.14.1667
   PubMed Web of Science ®Google Scholar
• Lin J-T, Yu X-Z, Cui D-J. A multicentre, randomized, controlled trial of oseltamivir in the treatment of influenza in a high-risk Chinese population. Curr Med Res Opin. 2006;22(1):75–82. doi:10.1185/030079906X80297
   PubMed Web of Science ®Google Scholar
• Wesseling G. Occasional review: influenza in COPD: pathogenesis, prevention, and treatment. Int J Chron Obstruct Pulmon Dis. 2007;2(1):5–10. doi:10.2147/copd.2007.2.1.5
   PubMedGoogle Scholar
• Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (2021 report); Available from: https://goldcopd.org/wp-content/uploads/2020/11/GOLD-REPORT-2021-v1.1-25Nov20_WMV.pdf. Accessed September 4, 2021.
   Google Scholar
• Wedzicha JA, Miravitlles M, Hurst JR, et al. Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline. Eur Respir J. 2017;49(3):1600791. doi:10.1183/13993003.00791-2016
   PubMed Web of Science ®Google Scholar
• National Clinical Guideline Centre (UK). Chronic obstructive pulmonary disease: management of chronic obstructive pulmonary disease in adults in primary and secondary care. London: Royal College of Physicians (UK); 2010. Available from: http://www.ncbi.nlm.nih.gov/books/NBK65039/. Accessed November 8, 2021.
   Google Scholar
• Vogelmeier CF, Criner GJ, Martinez FJ, et al. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary. Am J Respir Crit Care Med. 2017;195(5):557–582. doi:10.1164/rccm.201701-0218PP
   PubMed Web of Science ®Google Scholar
• Negewo NA, McDonald VM, Baines KJ, et al. Peripheral blood eosinophils: a surrogate marker for airway eosinophilia in stable COPD. COPD. 2016;11(1):1495–1504. doi:10.2147/COPD.S100338
   Google Scholar
• Jabarkhil A, Moberg M, Janner J, et al. Elevated blood eosinophils in acute COPD exacerbations: better short- and long-term prognosis. Eur Clin Respir J. 2020;7(1):1757274. doi:10.1080/20018525.2020.1757274
   PubMed Web of Science ®Google Scholar
• Jafarinejad H, Moghoofei M, Mostafaei S, Salimian J, Azimzadeh Jamalkandi S, Ahmadi A. Worldwide prevalence of viral infection in AECOPD patients: a meta-analysis. Microb Pathog. 2017;113:190–196. doi:10.1016/j.micpath.2017.10.021
   PubMed Web of Science ®Google Scholar
• Kawamatawong T, Apiwattanaporn A, Siricharoonwong W. Serum inflammatory biomarkers and clinical outcomes of COPD exacerbation caused by different pathogens. Int J Chron Obstruct Pulmon Dis. 2017;12:1625–1630. doi:10.2147/COPD.S132132
   PubMed Web of Science ®Google Scholar
• Jang JG, Ahn JH, Jin HJ. Incidence and prognostic factors of respiratory viral infections in severe acute exacerbation of chronic obstructive pulmonary disease. COPD. 2021;16:1265–1273. doi:10.2147/COPD.S306916
   Google Scholar
• Ko FWS, Ip M, Chan PKS, et al. Viral etiology of acute exacerbations of COPD in Hong Kong. Chest. 2007;132(3):900–908. doi:10.1378/chest.07-0530
   PubMed Web of Science ®Google Scholar
• Choi J, Oh JY, Lee YS, et al. Bacterial and viral identification rate in acute exacerbation of chronic obstructive pulmonary disease in Korea. Yonsei Med J. 2019;60(2):216–222. doi:10.3349/ymj.2019.60.2.216
   PubMed Web of Science ®Google Scholar
• Neuzil KM, O’Connor TZ, Gorse GJ, Nichol KL. Recognizing influenza in older patients with chronic obstructive pulmonary disease who have received influenza vaccine. Clin Infect Dis. 2003;36(2):169–174. doi:10.1086/345668
   PubMed Web of Science ®Google Scholar
• Tu YH, Guo Y, Ji S, Shen JL, Fei GH. The Influenza A Virus H3N2 Triggers the Hypersusceptibility of Airway Inflammatory Response via Activating the lncRNA TUG1/miR-145-5p/NF-κB Pathway in COPD. Front Pharmacol. 2021;12:604590. doi:10.3389/fphar.2021.604590
   PubMed Web of Science ®Google Scholar
• Verma N, Knight BP. The flu and atrial fibrillation: nothing to sneeze at. Heart Rhythm. 2016;13(6):1195–1196. doi:10.1016/j.hrthm.2016.01.025
   PubMed Web of Science ®Google Scholar
• Madjid M, Connolly AT, Nabutovsky Y, Safavi-Naeini P, Razavi M, Miller CC. Effect of high influenza activity on risk of ventricular arrhythmias requiring therapy in patients with implantable cardiac defibrillators and cardiac resynchronization therapy defibrillators. Am J Cardiol. 2019;124(1):44–50. doi:10.1016/j.amjcard.2019.04.011
   PubMed Web of Science ®Google Scholar
• Ison MG, Campbell V, Rembold C, Dent J, Hayden FG. Cardiac findings during uncomplicated acute influenza in ambulatory adults. Clin Infect Dis. 2005;40(3):415–422. doi:10.1086/427282
   PubMed Web of Science ®Google Scholar
• Chang TY, Chao TF, Liu CJ, et al. The association between influenza infection, vaccination, and atrial fibrillation: a nationwide case-control study. Heart Rhythm. 2016;13(6):1189–1194. doi:10.1016/j.hrthm.2016.01.026
   PubMed Web of Science ®Google Scholar
• Gopal R, Marinelli MA, Alcorn JF. Immune mechanisms in cardiovascular diseases associated with viral infection. Front Immunol. 2020;11:570681. doi:10.3389/fimmu.2020.570681
   PubMed Web of Science ®Google Scholar
• Lee IK, Liu JW, Wang L, Yang KD, Li CC, Eng HL. 2009 pandemic influenza A (H1N1): clinical and laboratory characteristics in pediatric and adult patients and in patients with pulmonary involvement. Influenza Other Respir Viruses. 2012;6(6):e152–161. doi:10.1111/j.1750-2659.2012.00410.x
   PubMed Web of Science ®Google Scholar
• Cate TR. Clinical manifestations and consequences of influenza. Am J Med. 1987;82(6A):15–19. doi:10.1016/0002-9343(87)90555-9
   PubMed Web of Science ®Google Scholar
• Scheinberg M, Blacklow NR, Goldstein AL, Parrino TA, Rose FB, Cathcart ES. Influenza: response of T-cell lymphopenia to thymosin. N Engl J Med. 1976;294(22):1208–1211. doi:10.1056/NEJM197605272942204
   PubMed Web of Science ®Google Scholar
• Vedel-Krogh S, Nielsen SF, Lange P, Vestbo J, Nordestgaard BG. Blood eosinophils and exacerbations in chronic obstructive pulmonary disease. The Copenhagen general population study. Am J Respir Crit Care Med. 2016;193(9):965–974. doi:10.1164/rccm.201509-1869OC
   PubMed Web of Science ®Google Scholar
• Bafadhel M, Peterson S, De Blas MA, et al. Predictors of exacerbation risk and response to budesonide in patients with chronic obstructive pulmonary disease: a post-hoc analysis of three randomised trials. Lancet Respir Med. 2018;6(2):117–126. doi:10.1016/S2213-2600(18)30006-7
   PubMed Web of Science ®Google Scholar
• Cheng SL. Blood eosinophils and inhaled corticosteroids in patients with COPD: systematic review and meta-analysis. Int J Chron Obstruct Pulmon Dis. 2018;13:2775–2784. doi:10.2147/COPD.S175017
   PubMed Web of Science ®Google Scholar
• Siddiqui SH, Pavord ID, Barnes NC, et al. Blood eosinophils: a biomarker of COPD exacerbation reduction with inhaled corticosteroids. Int J Chron Obstruct Pulmon Dis. 2018;13:3669–3676. doi:10.2147/COPD.S179425
   PubMed Web of Science ®Google Scholar
• Holland M, Alkhalil M, Chandromouli S, Janjua A, Babores M. Eosinopenia as a marker of mortality and length of stay in patients admitted with exacerbations of chronic obstructive pulmonary disease. Respirology. 2010;15(1):165–167. doi:10.1111/j.1440-1843.2009.01651.x
   PubMed Web of Science ®Google Scholar
• Wu HX, Zhuo KQ, Cheng DY. Peripheral blood eosinophil as a biomarker in outcomes of acute exacerbation of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2019;14:3003–3015. doi:10.2147/COPD.S226783
   PubMed Web of Science ®Google Scholar
• Couillard S, Larivée P, Courteau J, Vanasse A. Eosinophils in COPD exacerbations are associated with increased readmissions. Chest. 2017;151(2):366–373. doi:10.1016/j.chest.2016.10.003
   PubMed Web of Science ®Google Scholar
• MacDonald MI, Osadnik CR, Bulfin L, et al. Low and high blood eosinophil counts as biomarkers in hospitalized acute exacerbations of COPD. Chest. 2019;156(1):92–100. doi:10.1016/j.chest.2019.02.406
   PubMed Web of Science ®Google Scholar
• Wu CW, Lan CC, Hsieh PC, Tzeng IS, Wu YK. Role of peripheral eosinophilia in acute exacerbation of chronic obstructive pulmonary disease. World J Clin Cases. 2020;8(13):2727–2737. doi:10.12998/wjcc.v8.i13.2727
   PubMed Web of Science ®Google Scholar
• Tiwary M, Rooney RJ, Liedmann S, LeMessurier KS, Samarasinghe AE. Eosinophil Responses at the Airway Epithelial Barrier during the Early Phase of Influenza A Virus Infection in C57BL/6 Mice. Cells. 2021;10(3):509. doi:10.3390/cells10030509
   PubMed Web of Science ®Google Scholar
• Kherad O, Kaiser L, Bridevaux PO, et al. Upper-respiratory viral infection, biomarkers, and COPD exacerbations. Chest. 2010;138(4):896–904. doi:10.1378/chest.09-2225
   PubMed Web of Science ®Google Scholar
• Rohde G, Borg I, Wiethege A, et al. Inflammatory Response in Acute Viral Exacerbations of COPD. Infection. 2008;36(5):427–433. doi:10.1007/s15010-008-7327-5
   PubMed Web of Science ®Google Scholar
• Torres JP, Cordoba-Lanus E, López-Aguilar C, et al. C-reactive protein levels and clinically important predictive outcomes in stable COPD patients. Eur Respir J. 2006;27(5):902–907. doi:10.1183/09031936.06.00109605
   PubMed Web of Science ®Google Scholar
• Dahl M, Vestbo J, Lange P, Bojesen SE, Tybjaerg-Hansen A, Nordestgaard BG. C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2007;175(3):250–255. doi:10.1164/rccm.200605-713OC
   PubMed Web of Science ®Google Scholar
• Seemungal T, Donaldson GC, Paul EA, Bestall JC, Jeffries DJ, Wedzicha JA. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;157(5):1418–1422. doi:10.1164/ajrccm.157.5.9709032
   PubMed Web of Science ®Google Scholar
• Stuart RL, Cheng AC, Marshall CL, Ferguson JK. ASID (HICSIG) position statement: infection control guidelines for patients with influenza-like illnesses, including pandemic (H1N1) influenza 2009, in Australian health care facilities. Med J Aust. 2009;191(8):667. doi:10.5694/j.1326-5377.2009.tb03373.x
   PubMed Web of Science ®Google Scholar
• Chow A, Ma S, Ling AE, Chew SK. Influenza-associated Deaths in Tropical Singapore. Emerg Infect Dis. 2006;12(1):114–121. doi:10.3201/eid1201.050826
   PubMed Web of Science ®Google Scholar
• Beasley V, Joshi PV, Singanayagam A, Molyneaux PL, Johnston SL, Mallia P. Lung microbiology and exacerbations in COPD. Int J Chron Obstruct Pulmon Dis. 2012;7:555–569. doi:10.2147/COPD.S28286
   PubMed Web of Science ®Google Scholar